Clinical Trial | By B Pieske, MJ Patel, VICTORIA Study Group et al.
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
Clinical Trial | By PW Armstrong, B Pieske, the VICTORIA Study Group
BACKGROUND - The effect of vericiguat, a novel oral soluble guanylate cyclase stimulator, in patients with heart failure and reduced ejection fraction who had recently been hospitalized or had received intravenous diuretic therapy is unclear. METHODS - In this phase 3, randomized, double-blind, placebo-controlled trial, we assigned 5050 patients with chronic heart failure (New York Heart Association clas...
Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial
Clinical Trial | By JS Hochman, HR Reynolds, S Bangalore et al.
Clinical Trial | By ISCHEMIA Trial Research Group; DJ Maron, JS Hochman et al.
Review Article | By RA Kotronias, M Teitelbaum, JG Webb et al.
Original Research | By M Droppa, O Borst, T Katzenberger et al.
The year in cardiology: heart failure: The year in cardiology 2019